PIK3CA and breast carcinoma: Previous studies analyzed PIK3CA mutation prognostic impact in the whole breast cancer population and not specifically in TNBC [34], or evaluated together exon 9 and exon 20 PIK3CA mutations [32, 35], or analyzed their prognostic impact in small series (<100 patients with TNBC) [30, 35].